| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.01▲ | 3.02▼ | 3.02▼ | 3.12▼ | 3.08▼ |
| MA10 | 3.01▲ | 3.03▼ | 3.03▼ | 3.13▼ | 2.93▲ |
| MA20 | 3.02▼ | 3.03▼ | 3.07▼ | 3.09▼ | 2.79▲ |
| MA50 | 3.03▼ | 3.10▼ | 3.17▼ | 2.90▲ | 1.95▲ |
| MA100 | 3.04▼ | 3.16▼ | 3.12▼ | 2.74▲ | 2.03▲ |
| MA200 | 3.09▼ | 3.12▼ | 2.97▲ | 2.00▲ | 1.66▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.002▲ | -0.002▼ | -0.018▼ | -0.009▼ |
| RSI | 42.769▼ | 38.293▼ | 34.315▼ | 49.176▼ | 61.510▲ |
| STOCH | 33.929 | 31.263 | 23.044 | 40.270 | 59.807 |
| WILL %R | -75.000▼ | -90.909▼ | -86.957▼ | -81.283▼ | -48.866 |
| CCI | -46.667 | -129.333▼ | -157.967▼ | -90.483 | 36.595 |
|
Tuesday, October 06, 2026 05:00 PM
The former Gilead and Amgen commercial leader takes her seat as Entera’s Phase 3 trial nears its initiation. Entera Bio Ltd. (NASDAQ:ENTX), a clinical-stage developer of oral peptide therapies, ...
|
|
Friday, September 18, 2026 09:04 PM
Entera Bio Ltd. (NASDAQ: ENTX) has been initiated with coverage by Leerink Partners, which assigned the company an 'Outperform' rating and a price target of $9. As of the market close on September 17, ...
|
|
Sunday, August 30, 2026 05:00 PM
The drugs that rebuild bone are locked inside a channel most patients never reach. Entera (NASDAQ:ENTX) is nearing the pivotal trial built to change that, with a fully funded balance sheet, and an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/11/26 | 3.07 | 3.11 | 3.00 | 3.01 | 175,396 |
| 16/11/26 | 3.11 | 3.1165 | 3.00 | 3.02 | 208,609 |
| 13/11/26 | 3.22 | 3.265 | 3.08 | 3.11 | 155,346 |
| 12/11/26 | 3.20 | 3.24 | 3.13 | 3.22 | 170,483 |
| 11/11/26 | 3.275 | 3.275 | 3.13 | 3.22 | 103,427 |
| 10/11/26 | 3.25 | 3.25 | 3.17 | 3.24 | 98,553 |
| 09/11/26 | 3.17 | 3.4877 | 3.1101 | 3.25 | 512,162 |
| 06/11/26 | 3.03 | 3.18 | 2.91 | 3.14 | 118,328 |
| 05/11/26 | 3.07 | 3.10 | 2.90 | 2.99 | 219,756 |
| 04/11/26 | 3.05 | 3.20 | 3.05 | 3.11 | 291,239 |
|
|
||||
|
|
||||
|
|